Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Booth

Showing results (41-50 of 349) with videos related to

Pageof 35
Sort By:
JAMA Oncology|August 26, 2021
Has the Current Oncology Value Paradigm Forgotten Patients' Time?: Too Little of a Good ThingAdam Fundytus, Vinay Prasad, Christopher M Booth
Nature Reviews. Clinical Oncology|February 21, 2017
Approvals in 2016: questioning the clinical benefit of anticancer therapiesChristopher M Booth, Joseph C Del Paggio
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 17, 2019
What really matters at the end: perspectives from a patient, a family member and an oncologistRachel Koven, Penny Nelson, Christopher M Booth
Journal of the American Geriatrics Society|August 4, 2023
Common sense cancer care for older adults: Outcomes that matterChristopher Frank, Bishal Gyawali, Christopher M Booth
Seminars in Oncology|November 6, 2020
Toward affordable cancer drugs: Do we need firmer price negotiation, me-too drugs, or a biosimilar silver bullet?Adam Fundytus, Richard Sullivan, Christopher M Booth
JAMA Oncology|July 3, 2020
Risk of COVID-19 in Patients With CancerAndrew Robinson, Bishal Gyawali, Christopher M Booth
European Journal of Cancer (Oxford, England : 1990)|June 24, 2009
Clinical benefit in oncology trials: is this a patient-centred or tumour-centred end-point?Pavlo Ohorodnyk, Elizabeth A Eisenhauer, Christopher M Booth
Journal of the National Cancer Institute|June 5, 2024
Dietary interventions, statistical power, and unanswered questionsCalvin Smith, Christopher M Booth, Ghulam Rehman Mohyuddin
Nature Reviews. Clinical Oncology|March 1, 2020
Real-world evidence and regulatory drug approvalMichael J Raphael, Bishal Gyawali, Christopher M Booth
European Urology|March 16, 2021
Untangling the PROfound Trial for Advanced Prostate Cancer: Is There Really a Role for Olaparib?Daniel H Kwon, Christopher M Booth, Vinay Prasad
Pageof 35

Showing results (41-50 of 349) with videos related to

Sort By:
Pageof 35
JAMA Oncology|August 26, 2021
Has the Current Oncology Value Paradigm Forgotten Patients' Time?: Too Little of a Good ThingAdam Fundytus, Vinay Prasad, Christopher M Booth
Nature Reviews. Clinical Oncology|February 21, 2017
Approvals in 2016: questioning the clinical benefit of anticancer therapiesChristopher M Booth, Joseph C Del Paggio
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 17, 2019
What really matters at the end: perspectives from a patient, a family member and an oncologistRachel Koven, Penny Nelson, Christopher M Booth
Journal of the American Geriatrics Society|August 4, 2023
Common sense cancer care for older adults: Outcomes that matterChristopher Frank, Bishal Gyawali, Christopher M Booth
Seminars in Oncology|November 6, 2020
Toward affordable cancer drugs: Do we need firmer price negotiation, me-too drugs, or a biosimilar silver bullet?Adam Fundytus, Richard Sullivan, Christopher M Booth
JAMA Oncology|July 3, 2020
Risk of COVID-19 in Patients With CancerAndrew Robinson, Bishal Gyawali, Christopher M Booth
European Journal of Cancer (Oxford, England : 1990)|June 24, 2009
Clinical benefit in oncology trials: is this a patient-centred or tumour-centred end-point?Pavlo Ohorodnyk, Elizabeth A Eisenhauer, Christopher M Booth
Journal of the National Cancer Institute|June 5, 2024
Dietary interventions, statistical power, and unanswered questionsCalvin Smith, Christopher M Booth, Ghulam Rehman Mohyuddin
Nature Reviews. Clinical Oncology|March 1, 2020
Real-world evidence and regulatory drug approvalMichael J Raphael, Bishal Gyawali, Christopher M Booth
European Urology|March 16, 2021
Untangling the PROfound Trial for Advanced Prostate Cancer: Is There Really a Role for Olaparib?Daniel H Kwon, Christopher M Booth, Vinay Prasad
Pageof 35